Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-04
2008-03-04
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S272000, C544S323000, C544S332000, C544S297000, C544S334000, C544S319000, C568S030000, C568S036000, C560S013000, C564S095000, C564S440000
Reexamination Certificate
active
07338958
ABSTRACT:
This invention relates to pyrimidine derivatives of general formula Iin which Q, R1, R2, R3, R4, R5, X, and m have the meanings that are contained in the description, as inhibitors of cyclin-dependent kinases and VEGF-receptor tyrosine kinases, their production as well as their use as medications for treatment of various diseases.
REFERENCES:
patent: 2004/0063737 (2004-04-01), Luecking et al.
patent: 2004/0224966 (2004-11-01), Brumby et al.
patent: WO 98/41512 (1998-09-01), None
patent: WO 00/53595 (2000-09-01), None
patent: WO 01/64654 (2001-09-01), None
patent: WO 02/096887 (2002-12-01), None
patent: WO 02/096888 (2002-12-01), None
patent: WO 03/076437 (2003-09-01), None
Blain, et al., J Biolog. Chem., vol. 272, No. 41, 1997, pp. 25863-25872.
Rane, et al., Nature America, vol. 22, pp. 44-52, May 1999.
Leclerc, et al., J. Biolog. Chem., 276, No. 1, Jan. 2, 2001, pp. 251-260.
BBC News/Health, Jan. 21, 2006, 3 pages.
Wikipedia (Isomer) , Jan. 2007.
Wikipedia (Salt) , Jan. 2007.
Jautelat Rolf
Krueger Martin
Luecking Ulrich
Siemeister Gerhard
Berch Mark L.
Jaisle Cecilia M
Millen White Zelano & Branigan P.C.
Schering AG
LandOfFree
Sulfoximine-substituted pyrimidines as CDK-and/or VEGF... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfoximine-substituted pyrimidines as CDK-and/or VEGF..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfoximine-substituted pyrimidines as CDK-and/or VEGF... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2785221